Iovance Biotherapeutics, Inc. (IOVA) — 10-K Filings

All 10-K filings from Iovance Biotherapeutics, Inc.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.

10-K Filings (2)

  • IOVA Files 2024 10-K — Feb 27, 2025 Risk: medium
    IOVA filed its 2024 10-K on February 27, 2025, detailing its fiscal year ending December 31, 2024. The company, formerly known as Lion Biotechnologies, Inc., is
  • IOVANCE BIOTHERAPEUTICS, INC. Files 2023 10-K — Feb 28, 2024 Risk: medium
    IOVANCE BIOTHERAPEUTICS, INC. (IOVA) filed a Annual Report (10-K) with the SEC on February 28, 2024. IOVA filed its 2023 10-K on February 28, 2024. The company'

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.